Alvotech SA ALVO.OQ ALVO.O is expected to report resultson November 13 for the period ending September 30 2024
The Luxembourg Luxembourg-based company is expected to report revenue of $89 million, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Alvotech SA is for a loss of 6 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Alvotech SA is $19.50, above its last closing price of $12.21.
This summary was machine generated November 12 at 03:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments